Assisted Reproductive Technology Market size was valued at USD 35 Billion in 2023 and is set to exceed USD 76 Billion by the end of 2036, registering over 7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of assisted reproductive technology is assessed at USD 37.1 Billion.
It is believed that the rising burden of infertility is driving innovations in the field of assisted reproductive technology (ART) that covers all reproductive procedures that deal with eggs or embryos. As per the World Health Organization (WHO), approximately 1 in 6 adults globally, or 17.5% of the population, are infertile.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
7% |
|
Base Year Market Size (2023) |
USD 35 Billion |
|
Forecast Year Market Size (2036) |
USD 76 Billion |
|
Regional Scope |
|
Technology (In-vitro Fertilization (IVF), Artificial Insemination, Frozen Embryo Replacement (FER), Surrogacy, Ovulation Induction)
In-vitro fertilization (IVF) segment is likely to capture around 92% assisted reproductive technology market share by the end of 2036. The segment growth can be attributed to the rising number of in-vitro fertilization (IVF) procedures across the globe. The most popular form of assisted reproductive technology is in vitro fertilization which helps in infertility treatment.
IVF is also known as unaided or spontaneous conception in which sperm and eggs are mixed in a lab to generate an embryo. For instance, globally, more than 5 million IVF babies have been born, and over 2 million cycles are carried out annually, translating into around 400,000 births.
End-Use (Fertility clinics, Hospitals, Gynecology Centers, Feminist Health Centers, IVF Centers, Clinics, Diagnostic centers)
Fertility clinics segment in the assisted reproductive technology market is predicted to cross USD 19 Billion by the end of 2036 led by the growing cases of delayed marriage. More than 4% of women worldwide reach their late forties without ever getting married.
Late-married couples frequently experience infertility, which increases their trips to fertility clinics that provide the best assisted reproductive technology (ART) alternatives to help couples and even single individuals who want to start a family.
Product (Instrument, Accessory & Disposable, Reagents & media)
The accessory & disposable segment is assessed to generate substantial CAGR by the end of 2036. The growth of the segment can be accredited to the rising usage of catheters. For instance, every year, more than 4 million central venous catheters are implanted.
Soft embryo transfer catheters are used instead of rigid catheters and are examples of accessories and disposables that are utilized during ART treatments for embryo transfer, which noticeably raises the pregnancy rate.
One treatment for infertility is intrauterine insemination or IUI an assisted reproductive technology method where sperm are inserted into a woman's uterus via a catheter to aid in fertilization.
Our in-depth analysis of the market includes the following segments:
|
End-Use |
|
|
Technology |
|
|
Product |
|
|
Diagnosis |
|
North American Market Statistics
North America in assisted reproductive technology market is expected to hold more than 35% revenue share by 2036. The market demand in the region is also expected on account of the rising personal disposable income. This has led to a rise in assisted reproductive technology services since with increased income more people to afford these treatments.
Infertility treatment in the United States often involves in vitro fertilization, which is an intricate set of steps that can result in pregnancy. For instance, more than 2% of all babies born in the United States in 2021 were made possible by assisted reproductive technology. In the United States, more than 720 infants are delivered through gestational surrogacy every year since it is less complicated legally.
Besides this, in Ontario, Canada assisted reproductive technology (ART) is used in over 1% of births; this percentage has been increasing.
APAC Market Analysis
The Asia Pacific region will also encounter massive revenue for the assisted reproductive technology market through 2036. The need for IVF therapy is anticipated to rise in the Asia-Pacific area since the number of travelers from across the globe is seeking medical treatments including reproductive treatment in nations like Thailand, China, Japan, India, and other nations.
The IVF business in Japan grew as a result of high levels of disposable income among Japanese citizens, and easily available financial assistance for the treatment.
China's sperm donation facilities, located in Beijing and Shanghai among other places, are urging healthy men and college students to donate their sperm following the nation's first negative population increase in 61 years. For instance, there were more than 25 human sperm banks on the Chinese mainland between 1981 and 2020.
The assisted reproductive technology market consists of many key players who are launching various strategic initiatives to expand their market position in the industry.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?